Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Alessa Therapeutics Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06257693
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
Phase 1
Active, not recruiting
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Radiation: Stereotactic body radiation therapy
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Alessa Therapeutics Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04943536
- Locations
- 🇺🇸
National Cancer Institute, Bethesda, Maryland, United States
A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate AdenocarcinomaLower Urinary Tract Symptoms
- First Posted Date
- 2020-02-26
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Alessa Therapeutics Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT04284761
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇦🇺Australian Clinical Trials, Wahroonga, New South Wales, Australia
🇦🇺University of Wollongong, Wollongong, New South Wales, Australia
News
No news found